Access Clinical Trials, Inc.

Nashville, Tennessee 37203-6502

3 studies enrolling now · 17 studies all time

What they study most

ADHD, ADHD - Combined Type, Acute Migraine, Acute Treatment of Migraine, Arthritis, Rheumatoid, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder Combined, Attention-deficit Hyperactivity, Epilepsy, Gastrointestinal Dysmotility

Studies at this site

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder — Running, not enrolling
• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults — Completed
• Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder — Available (expanded access)
• Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 — Completed
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension — Completed
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents — Completed
• Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures — Completed
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) — Stopped early
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures — Stopped early
• Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) — Completed
• Ulimorelin Study of Efficacy and Safety (ULISES 008) — Completed